Current concepts on the immunopathogenesis of inflammatory bowel disease

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 4, 2012, Pages 1451-1477

  Vora, Puja ^a,b   Shih, David Quan ^a   McGovern, Dermot Patrick ^a   Targan, Stephan Raoul ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adaptive Immunity; Autophagy; Bacterial Host Interactions; Crohn's Disease; Innate Immunity; Microbiome; Review; Ulcerative Colitis

Indexed keywords

AMYLOID A PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; FC RECEPTOR; FUCOSYLTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 27; INTERLEUKIN 6; JANUS KINASE 2; MESSENGER RNA; MUCIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROSTAGLANDIN E RECEPTOR 4; SERUM AMYLOID A; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; AUTOPHAGY; BACTEROIDES FRAGILIS; CHRONIC INFLAMMATION; CLINICAL FEATURE; CROHN DISEASE; ENDOPLASMIC RETICULUM STRESS; EPITHELIUM CELL; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTESTINE FLORA; META ANALYSIS (TOPIC); MICROBIOME; MUCOSA INFLAMMATION; PANETH CELL; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH MUCUS; T LYMPHOCYTE ACTIVATION; TH17 CELL; ULCERATIVE COLITIS; WNT SIGNALING PATHWAY; ADAPTATION; ENTERITIS; GENETIC EPISTASIS; GENETICS; IMMUNOLOGY; MICROBIOLOGY;

BACTERIA (MICROORGANISMS);

ADAPTATION, PHYSIOLOGICAL; EPISTASIS, GENETIC; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES;

EID: 84858413324     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Review

References (164)

1. A. Kornbluth and D. B. Sachar: Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol, 105(3), 501-23; quiz 524 (2010)
2. G. R. Lichtenstein, S. B. Hanauer and W. J. Sandborn: Management of Crohn's disease in adults. Am J Gastroenterol, 104(2), 465-83; quiz 464, 484 (2009)
3. J. H. Cho and C. T. Weaver: The genetics of inflammatory bowel disease. Gastroenterology, 133(4), 1327-39 (2007) (Pubitemid 47494470)
4. J. P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J. P. Cezard, J. Belaiche, S. Almer, C. Tysk, C. A. O'Morain, M. Gassull, V. Binder, Y. Finkel, A. Cortot, R. Modigliani, P. Laurent-Puig, C. Gower-Rousseau, J. Macry, J. F. Colombel, M. Sahbatou and G. Thomas: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411(6837), 599-603 (2001) (Pubitemid 32531408)
5. Y. Ogura, D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. H. Duerr, J. P. Achkar, S. R. Brant, T. M. Bayless, B. S. Kirschner, S. B. Hanauer, G. Nunez and J. H. Cho: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411(6837), 603-6 (2001) (Pubitemid 32531409)
6. K. Yamazaki, D. McGovern, J. Ragoussis, M. Paolucci, H. Butler, D. Jewell, L. Cardon, M. Takazoe, T. Tanaka, T. Ichimori, S. Saito, A. Sekine, A. Iida, A. Takahashi, T. Tsunoda, M. Lathrop and Y. Nakamura: Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet, 14(22), 3499-506 (2005) (Pubitemid 41672132)
7. Y. Picornell, L. Mei, K. Taylor, H. Yang, S. R. Targan and J. I. Rotter: TNFSF15 is an ethnic-specific IBD gene. Inflamm Bowel Dis, 13(11), 1333-8 (2007)
8. R. Thiebaut, S. Kotti, C. Jung, F. Merlin, J. F. Colombel, M. Lemann, S. Almer, C. Tysk, M. O'Morain, M. Gassull, V. Binder, Y. Finkel, L. Pascoe and J. P. Hugot: TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. Am J Gastroenterol, 104(2), 384-91 (2009)
9. M. Tremelling, C. Berzuini, D. Massey, F. Bredin, C. Price, C. Dawson, S. A. Bingham and M. Parkes: Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm Bowel Dis, 14(6), 733-7 (2008) (Pubitemid 351898055)
10. A. Franke, D. P. McGovern, J. C. Barrett, K. Wang, G. L. Radford-Smith, T. Ahmad, C. W. Lees, T. Balschun, J. Lee, R. Roberts, C. A. Anderson, J. C. Bis, S. Bumpstead, D. Ellinghaus, E. M. Festen, M. Georges, T. Green, T. Haritunians, L. Jostins, A. Latiano, C. G. Mathew, G. W. Montgomery, N. J. Prescott, S. Raychaudhuri, J. I. Rotter, P. Schumm, Y. Sharma, L. A. Simms, K. D. Taylor, D. Whiteman, C. Wijmenga, R. N. Baldassano, M. Barclay, T. M. Bayless, S. Brand, C. Buning, A. Cohen, J. F. Colombel, M. Cottone, L. Stronati, T. Denson, M. De Vos, R. D'Inca, M. Dubinsky, C. Edwards, T. Florin, D. Franchimont, R. Gearry, J. Glas, A. Van Gossum, S. L. Guthery, J. Halfvarson, H. W. Verspaget, J. P. Hugot, A. Karban, D. Laukens, I. Lawrance, M. Lemann, A. Levine, C. Libioulle, E. Louis, C. Mowat, W. Newman, J. Panes, A. Phillips, D. D. Proctor, M. Regueiro, R. Russell, P. Rutgeerts, J. Sanderson, M. Sans, F. Seibold, A. H. Steinhart, P. C. Stokkers, L. Torkvist, G. Kullak-Ublick, D. Wilson, T. Walters, S. R. Targan, S. R. Brant, J. D. Rioux, M. D'Amato, R. K. Weersma, S. Kugathasan, A. M. Griffiths, J. C. Mansfield, S. Vermeire, R. H. Duerr, M. S. Silverberg, J. Satsangi, S. Schreiber, J. H. Cho, V. Annese, H. Hakonarson, M. J. Daly and M. Parkes: Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010)
11. Y. Kakuta, Y. Kinouchi, K. Negoro, S. Takahashi and T. Shimosegawa: Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease. Gut, 55(10), 1527-8 (2006)
12. S. K. Yang, J. Lim, H. S. Chang, I. Lee, Y. Li, J. Liu and K. Song: Association of TNFSF15 with Crohn's disease in Koreans. Am J Gastroenterol, 103(6), 1437-42 (2008) (Pubitemid 351813898)
13. F. R. Zhang, W. Huang, S. M. Chen, L. D. Sun, H. Liu, Y. Li, Y. Cui, X. X. Yan, H. T. Yang, R. D. Yang, T. S. Chu, C. Zhang, L. Zhang, J. W. Han, G. Q. Yu, C. Quan, Y. X. Yu, Z. Zhang, B. Q. Shi, L. H. Zhang, H. Cheng, C. Y. Wang, Y. Lin, H. F. Zheng, X. A. Fu, X. B. Zuo, Q. Wang, H. Long, Y. P. Sun, Y. L. Cheng, H. Q. Tian, F. S. Zhou, H. X. Liu, W. S. Lu, S. M. He, W. L. Du, M. Shen, Q. Y. Jin, Y. Wang, H. Q. Low, T. Erwin, N. H. Yang, J. Y. Li, X. Zhao, Y. L. Jiao, L. G. Mao, G. Yin, Z. X. Jiang, X. D. Wang, J. P. Yu, Z. H. Hu, C. H. Gong, Y. Q. Liu, R. Y. Liu, D. M. Wang, D. Wei, J. X. Liu, W. K. Cao, H. Z. Cao, Y. P. Li, W. G. Yan, S. Y. Wei, K. J. Wang, M. L. Hibberd, S. Yang, X. J. Zhang and J. J. Liu: Genomewide association study of leprosy. N Engl J Med, 361(27), 2609-18 (2009)
14. R. H. Duerr, K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, T. Dassopoulos, A. Bitton, H. Yang, S. Targan, L. W. Datta, E. O. Kistner, L. P. Schumm, A. T. Lee, P. K. Gregersen, M. M. Barmada, J. I. Rotter, D. L. Nicolae and J. H. Cho: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science, 314(5804), 1461-3 (2006)
15. J. D. Rioux, R. J. Xavier, K. D. Taylor, M. S. Silverberg, P. Goyette, A. Huett, T. Green, P. Kuballa, M. M. Barmada, L. W. Datta, Y. Y. Shugart, A. M. Griffiths, S. R. Targan, A. F. Ippoliti, E. J. Bernard, L. Mei, D. L. Nicolae, M. Regueiro, L. P. Schumm, A. H. Steinhart, J. I. Rotter, R. H. Duerr, J. H. Cho, M. J. Daly and S. R. Brant: Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet, 39(5), 596-604 (2007) (Pubitemid 46676115)
16. J. Hampe, A. Franke, P. Rosenstiel, A. Till, M. Teuber, K. Huse, M. Albrecht, G. Mayr, F. M. De La Vega, J. Briggs, S. Gunther, N. J. Prescott, C. M. Onnie, R. Hasler, B. Sipos, U. R. Folsch, T. Lengauer, M. Platzer, C. G. Mathew, M. Krawczak and S. Schreiber: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet, 39(2), 207-11 (2007) (Pubitemid 46184351)
17. P. R. Burton, D. G. Clayton, L. R. Cardon, N. Craddock, P. Deloukas, A. Duncanson, D. P. Kwiatkowski, M. I. McCarthy, W. H. Ouwehand, N. J. Samani, J. A. Todd, P. Donnelly, J. C. Barrett, D. Davison, D. Easton, D. M. Evans, H. T. Leung, J. L. Marchini, A. P. Morris, C. C. Spencer, M. D. Tobin, A. P. Attwood, J. P. Boorman, B. Cant, U. Everson, J. M. Hussey, J. D. Jolley, A. S. Knight, K. Koch, E. Meech, S. Nutland, C. V. Prowse, H. E. Stevens, N. C. Taylor, G. R. Walters, N. M. Walker, N. A. Watkins, T. Winzer, R. W. Jones, W. L. McArdle, S. M. Ring, D. P. Strachan, M. Pembrey, G. Breen, D. St Clair, S. Caesar, K. Gordon-Smith, L. Jones, C. Fraser, E. K. Green, D. Grozeva, M. L. Hamshere, P. A. Holmans, I. R. Jones, G. Kirov, V. Moskivina, I. Nikolov, M. C. O'Donovan, M. J. Owen, D. A. Collier, A. Elkin, A. Farmer, R. Williamson, P. McGuffin, A. H. Young, I. N. Ferrier, S. G. Ball, A. J. Balmforth, J. H. Barrett, T. D. Bishop, M. M. Iles, A. Maqbool, N. Yuldasheva, A. S. Hall, P. S. Braund, R. J. Dixon, M. Mangino, S. Stevens, J. R. Thompson, F. Bredin, M. Tremelling, M. Parkes, H. Drummond, C. W. Lees, E. R. Nimmo, J. Satsangi, S. A. Fisher, A. Forbes, C. M. Lewis, C. M. Onnie, N. J. Prescott, J. Sanderson, C. G. Matthew, J. Barbour, M. K. Mohiuddin, C. E. Todhunter, J. C. Mansfield, T. Ahmad, F. R. Cummings, D. P. Jewell, J. Webster, M. J. Brown, M. G. Lathrop, J. Connell, A. Dominiczak, C. A. Marcano, B. Burke, R. Dobson, J. Gungadoo, K. L. Lee, P. B. Munroe, S. J. Newhouse, A. Onipinla, C. Wallace, M. Xue, M. Caulfield, M. Farrall, A. Barton, I. N. Bruce, H. Donovan, S. Eyre, P. D. Gilbert, S. L. Hilder, A. M. Hinks, S. L. John, C. Potter, A. J. Silman, D. P. Symmons, W. Thomson, J. Worthington, D. B. Dunger, B. Widmer, T. M. Frayling, R. M. Freathy, H. Lango, J. R. Perry, B. M. Shields, M. N. Weedon, A. T. Hattersley, G. A. Hitman, M. Walker, K. S. Elliott, C. J. Groves, C. M. Lindgren, N. W. Rayner, N. J. Timpson, E. Zeggini, M. Newport, G. Sirugo, E. Lyons, F. Vannberg, A. V. Hill, L. A. Bradbury, C. Farrar, J. J. Pointon, P. Wordsworth, M. A. Brown, J. A. Franklyn, J. M. Heward, M. J. Simmonds, S. C. Gough, S. Seal, M. R. Stratton, N. Rahman, M. Ban, A. Goris, S. J. Sawcer, A. Compston, D. Conway, M. Jallow, K. A. Rockett, S. J. Bumpstead, A. Chaney, K. Downes, M. J. Ghori, R. Gwilliam, S. E. Hunt, M. Inouye, A. Keniry, E. King, R. McGinnis, S. Potter, R. Ravindrarajah, P. Whittaker, C. Widden, D. Withers, N. J. Cardin, T. Ferreira, J. Pereira-Gale, I. B. Hallgrimsdo'ttir, B. N. Howie, Z. Su, Y. Y. Teo, D. Vukcevic, D. Bentley, S. L. Mitchell, P. R. Newby, O. J. Brand, J. Carr-Smith, S. H. Pearce, J. D. Reveille, X. Zhou, A. M. Sims, A. Dowling, J. Taylor, T. Doan, J. C. Davis, L. Savage, M. M. Ward, T. L. Learch, M. H. Weisman and M. Brown: Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet, 39(11), 1329-37 (2007) (Pubitemid 350041542)
18. M. Parkes, J. C. Barrett, N. J. Prescott, M. Tremelling, C. A. Anderson, S. A. Fisher, R. G. Roberts, E. R. Nimmo, F. R. Cummings, D. Soars, H. Drummond, C. W. Lees, S. A. Khawaja, R. Bagnall, D. A. Burke, C. E. Todhunter, T. Ahmad, C. M. Onnie, W. McArdle, D. Strachan, G. Bethel, C. Bryan, C. M. Lewis, P. Deloukas, A. Forbes, J. Sanderson, D. P. Jewell, J. Satsangi, J. C. Mansfield, L. Cardon and C. G. Mathew: Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet, 39(7), 830-2 (2007) (Pubitemid 47014496)
19. C. Libioulle, E. Louis, S. Hansoul, C. Sandor, F. Farnir, D. Franchimont, S. Vermeire, O. Dewit, M. de Vos, A. Dixon, B. Demarche, I. Gut, S. Heath, M. Foglio, L. Liang, D. Laukens, M. Mni, D. Zelenika, A. Van Gossum, P. Rutgeerts, J. Belaiche, M. Lathrop and M. Georges: Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet, 3(4), e58 (2007)
20. J. C. Barrett, S. Hansoul, D. L. Nicolae, J. H. Cho, R. H. Duerr, J. D. Rioux, S. R. Brant, M. S. Silverberg, K. D. Taylor, M. M. Barmada, A. Bitton, T. Dassopoulos, L. W. Datta, T. Green, A. M. Griffiths, E. O. Kistner, M. T. Murtha, M. D. Regueiro, J. I. Rotter, L. P. Schumm, A. H. Steinhart, S. R. Targan, R. J. Xavier, C. Libioulle, C. Sandor, M. Lathrop, J. Belaiche, O. Dewit, I. Gut, S. Heath, D. Laukens, M. Mni, P. Rutgeerts, A. Van Gossum, D. Zelenika, D. Franchimont, J. P. Hugot, M. de Vos, S. Vermeire, E. Louis, L. R. Cardon, C. A. Anderson, H. Drummond, E. Nimmo, T. Ahmad, N. J. Prescott, C. M. Onnie, S. A. Fisher, J. Marchini, J. Ghori, S. Bumpstead, R. Gwilliam, M. Tremelling, P. Deloukas, J. Mansfield, D. Jewell, J. Satsangi, C. G. Mathew, M. Parkes, M. Georges and M. J. Daly: Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet, 40(8), 955-62 (2008)
21. M. Imielinski, R. N. Baldassano, A. Griffiths, R. K. Russell, V. Annese, M. Dubinsky, S. Kugathasan, J. P. Bradfield, T. D. Walters, P. Sleiman, C. E. Kim, A. Muise, K. Wang, J. T. Glessner, S. Saeed, H. Zhang, E. C. Frackelton, C. Hou, J. H. Flory, G. Otieno, R. M. Chiavacci, R. Grundmeier, M. Castro, A. Latiano, B. Dallapiccola, J. Stempak, D. J. Abrams, K. Taylor, D. McGovern, G. Silber, I. Wrobel, A. Quiros, J. C. Barrett, S. Hansoul, D. L. Nicolae, J. H. Cho, R. H. Duerr, J. D. Rioux, S. R. Brant, M. S. Silverberg, K. D. Taylor, M. M. Barmuda, A. Bitton, T. Dassopoulos, L. W. Datta, T. Green, A. M. Griffiths, E. O. Kistner, M. T. Murtha, M. D. Regueiro, J. I. Rotter, L. P. Schumm, A. H. Steinhart, S. R. Targan, R. J. Xavier, C. Libioulle, C. Sandor, M. Lathrop, J. Belaiche, O. Dewit, I. Gut, S. Heath, D. Laukens, M. Mni, P. Rutgeerts, A. Van Gossum, D. Zelenika, D. Franchimont, J. P. Hugot, M. de Vos, S. Vermeire, E. Louis, L. R. Cardon, C. A. Anderson, H. Drummond, E. Nimmo, T. Ahmad, N. J. Prescott, C. M. Onnie, S. A. Fisher, J. Marchini, J. Ghori, S. Bumpstead, R. Gwillam, M. Tremelling, P. Delukas, J. Mansfield, D. Jewell, J. Satsangi, C. G. Mathew, M. Parkes, M. Georges, M. J. Daly, M. B. Heyman, G. D. Ferry, B. Kirschner, J. Lee, J. Essers, R. Grand, M. Stephens, A. Levine, D. Piccoli, J. Van Limbergen, S. Cucchiara, D. S. Monos, S. L. Guthery, L. Denson, D. C. Wilson, S. F. Grant, M. Daly and H. Hakonarson: Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet, 41(12), 1335-40 (2009)
22. D. P. McGovern, M. R. Jones, K. D. Taylor, K. Marciante, X. Yan, M. Dubinsky, A. Ippoliti, E. Vasiliauskas, D. Berel, C. Derkowski, D. Dutridge, P. Fleshner, D. Q. Shih, G. Melmed, E. Mengesha, L. King, S. Pressman, T. Haritunians, X. Guo, S. R. Targan and J. I. Rotter: Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet, 19(17), 3468-76 (2010)
23. S. Lesage, H. Zouali, J. P. Cezard, J. F. Colombel, J. Belaiche, S. Almer, C. Tysk, C. O'Morain, M. Gassull, V. Binder, Y. Finkel, R. Modigliani, C. Gower-Rousseau, J. Macry, F. Merlin, M. Chamaillard, A. S. Jannot, G. Thomas and J. P. Hugot: CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet, 70(4), 845-57 (2002) (Pubitemid 34259301)
24. M. S. Silverberg, J. H. Cho, J. D. Rioux, D. P. McGovern, J. Wu, V. Annese, J. P. Achkar, P. Goyette, R. Scott, W. Xu, M. M. Barmada, L. Klei, M. J. Daly, C. Abraham, T. M. Bayless, F. Bossa, A. M. Griffiths, A. F. Ippoliti, R. G. Lahaie, A. Latiano, P. Pare, D. D. Proctor, M. D. Regueiro, A. H. Steinhart, S. R. Targan, L. P. Schumm, E. O. Kistner, A. T. Lee, P. K. Gregersen, J. I. Rotter, S. R. Brant, K. D. Taylor, K. Roeder and R. H. Duerr: Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet, 41(2), 216-20 (2009)
25. S. A. Fisher, M. Tremelling, C. A. Anderson, R. Gwilliam, S. Bumpstead, N. J. Prescott, E. R. Nimmo, D. Massey, C. Berzuini, C. Johnson, J. C. Barrett, F. R. Cummings, H. Drummond, C. W. Lees, C. M. Onnie, C. E. Hanson, K. Blaszczyk, M. Inouye, P. Ewels, R. Ravindrarajah, A. Keniry, S. Hunt, M. Carter, N. Watkins, W. Ouwehand, C. M. Lewis, L. Cardon, A. Lobo, A. Forbes, J. Sanderson, D. P. Jewell, J. C. Mansfield, P. Deloukas, C. G. Mathew, M. Parkes and J. Satsangi: Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet, 40(6), 710-2 (2008) (Pubitemid 351748865)
26. A. Franke, T. Balschun, T. H. Karlsen, J. Sventoraityte, S. Nikolaus, G. Mayr, F. S. Domingues, M. Albrecht, M. Nothnagel, D. Ellinghaus, C. Sina, C. M. Onnie, R. K. Weersma, P. C. Stokkers, C. Wijmenga, M. Gazouli, D. Strachan, W. L. McArdle, S. Vermeire, P. Rutgeerts, P. Rosenstiel, M. Krawczak, M. H. Vatn, C. G. Mathew and S. Schreiber: Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet, 40(11), 1319-23 (2008)
27. K. Asano, T. Matsushita, J. Umeno, N. Hosono, A. Takahashi, T. Kawaguchi, T. Matsumoto, T. Matsui, Y. Kakuta, Y. Kinouchi, T. Shimosegawa, M. Hosokawa, Y. Arimura, Y. Shinomura, Y. Kiyohara, T. Tsunoda, N. Kamatani, M. Iida, Y. Nakamura and M. Kubo: A genomewide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet, 41(12), 1325-9 (2009)
28. D. P. McGovern, A. Gardet, L. Torkvist, P. Goyette, J. Essers, K. D. Taylor, B. M. Neale, R. T. Ong, C. Lagace, C. Li, T. Green, C. R. Stevens, C. Beauchamp, P. R. Fleshner, M. Carlson, M. D'Amato, J. Halfvarson, M. L. Hibberd, M. Lordal, L. Padyukov, A. Andriulli, E. Colombo, A. Latiano, O. Palmieri, E. J. Bernard, C. Deslandres, D. W. Hommes, D. J. de Jong, P. C. Stokkers, R. K. Weersma, Y. Sharma, M. S. Silverberg, J. H. Cho, J. Wu, K. Roeder, S. R. Brant, L. P. Schumm, R. H. Duerr, M. C. Dubinsky, N. L. Glazer, T. Haritunians, A. Ippoliti, G. Y. Melmed, D. S. Siscovick, E. A. Vasiliauskas, S. R. Targan, V. Annese, C. Wijmenga, S. Pettersson, J. I. Rotter, R. J. Xavier, M. J. Daly, J. D. Rioux and M. Seielstad: Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet, 42(4), 332-7 (2010)
29. R. Gonsky, R. L. Deem, C. J. Landers, C. A. Derkowski, D. Berel, D. P. McGovern and S. R. Targan: Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens. Inflamm Bowel Dis, 17(1), 171-8 (2011)
30. D. Q. Shih and S. R. Targan: Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol, 14(3), 390-400 (2008) (Pubitemid 351320847)
31. P. B. Eckburg, E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill, K. E. Nelson and D. A. Relman: Diversity of the human intestinal microbial flora. Science, 308(5728), 1635-8 (2005)
32. J. Qin, R. Li, J. Raes, M. Arumugam, K. S. Burgdorf, C. Manichanh, T. Nielsen, N. Pons, F. Levenez, T. Yamada, D. R. Mende, J. Li, J. Xu, S. Li, D. Li, J. Cao, B. Wang, H. Liang, H. Zheng, Y. Xie, J. Tap, P. Lepage, M. Bertalan, J. M. Batto, T. Hansen, D. Le Paslier, A. Linneberg, H. B. Nielsen, E. Pelletier, P. Renault, T. Sicheritz-Ponten, K. Turner, H. Zhu, C. Yu, M. Jian, Y. Zhou, Y. Li, X. Zhang, N. Qin, H. Yang, J. Wang, S. Brunak, J. Dore, F. Guarner, K. Kristiansen, O. Pedersen, J. Parkhill, J. Weissenbach, P. Bork and S. D. Ehrlich: A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464(7285), 59-65 (2010)
33. S. Nell, S. Suerbaum and C. Josenhans: The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol, 8(8), 564-77 (2010)
34. B. A. Duerkop, S. Vaishnava and L. V. Hooper: Immune responses to the microbiota at the intestinal mucosal surface. Immunity, 31(3), 368-76 (2009)
35. R. J. Kelly, S. Rouquier, D. Giorgi, G. G. Lennon and J. B. Lowe: Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the nonsecretor phenotype. J Biol Chem, 270(9), 4640-9 (1995)
36. B. Carlsson, E. Kindberg, J. Buesa, G. E. Rydell, M. F. Lidon, R. Montava, R. Abu Mallouh, A. Grahn, J. Rodriguez-Diaz, J. Bellido, A. Arnedo, G. Larson and L. Svensson: The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS One, 4(5), e5593 (2009)
37. S. Marionneau, F. Airaud, N. V. Bovin, J. Le Pendu and N. Ruvoen-Clouet: Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis, 192(6), 1071-7 (2005)
38. M. Thorven, A. Grahn, K. O. Hedlund, H. Johansson, C. Wahlfrid, G. Larson and L. Svensson: A homozygous nonsense mutation (428G - >A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol, 79(24), 15351-5 (2005)
39. C. C. Blackwell, K. Jonsdottir, M. Hanson, W. T. Todd, A. K. Chaudhuri, B. Mathew, R. P. Brettle and D. M. Weir: Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet, 2(8501), 284-5 (1986) (Pubitemid 16063776)
40. C. C. Blackwell, K. Jonsdottir, M. F. Hanson and D. M. Weir: Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet, 2(8508), 687 (1986) (Pubitemid 16029397)
41. D. A. Evans, L. Horwich, R. B. McConnell and M. F. Bullen: Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer. Gut, 9(3), 319-22 (1968)
42. S. Wu, K. J. Rhee, E. Albesiano, S. Rabizadeh, X. Wu, H. R. Yen, D. L. Huso, F. L. Brancati, E. Wick, F. McAllister, F. Housseau, D. M. Pardoll and C. L. Sears: A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med, 15(9), 1016-22 (2009)
43. J. L. Round and S. K. Mazmanian: Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A, 107(27), 12204-9 (2010)
44. J. Ochoa-Reparaz, D. W. Mielcarz, Y. Wang, S. Begum-Haque, S. Dasgupta, D. L. Kasper and L. H. Kasper: A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol, 3(5), 487-95 (2010)
45. Ivanov, II, K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, T. Tanoue, A. Imaoka, K. Itoh, K. Takeda, Y. Umesaki, K. Honda and D. R. Littman: Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell, 139(3), 485-98 (2009)
46. T. B. Clarke, K. M. Davis, E. S. Lysenko, A. Y. Zhou, Y. Yu and J. N. Weiser: Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med, 16(2), 228-31 (2010)
47. P. Dharmani, V. Srivastava, V. Kissoon-Singh and K. Chadee: Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun, 1(2), 123-35 (2009)
48. J. Van Limbergen, R. K. Russell, E. R. Nimmo, G. T. Ho, I. D. Arnott, D. C. Wilson and J. Satsangi: Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis, 13(3), 338-55 (2007) (Pubitemid 46465916)
49. A. W. Einerhand, I. B. Renes, M. K. Makkink, M. van der Sluis, H. A. Buller and J. Dekker: Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur J Gastroenterol Hepatol, 14(7), 757-65 (2002) (Pubitemid 34753960)
50. V. D. Peltekova, R. F. Wintle, L. A. Rubin, C. I. Amos, Q. Huang, X. Gu, B. Newman, M. Van Oene, D. Cescon, G. Greenberg, A. M. Griffiths, P. H. St George-Hyslop and K. A. Siminovitch: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet, 36(5), 471-5 (2004) (Pubitemid 38620030)
51. W. E. Roediger and S. Nance: Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp Pathol, 67(6), 773-82 (1986) (Pubitemid 17212913)
52. M. Stoll, B. Corneliussen, C. M. Costello, G. H. Waetzig, B. Mellgard, W. A. Koch, P. Rosenstiel, M. Albrecht, P. J. Croucher, D. Seegert, S. Nikolaus, J. Hampe, T. Lengauer, S. Pierrou, U. R. Foelsch, C. G. Mathew, M. Lagerstrom-Fermer and S. Schreiber: Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet, 36(5), 476-80 (2004) (Pubitemid 38620031)
53. X. Wu, K. Hepner, S. Castelino-Prabhu, D. Do, M. B. Kaye, X. J. Yuan, J. Wood, C. Ross, C. L. Sawyers and Y. E. Whang: Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A, 97(8), 4233-8 (2000)
54. Y. Hu, Z. Li, L. Guo, L. Wang, L. Zhang, X. Cai, H. Zhao and X. Zha: MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells. Arch Biochem Biophys, 467(1), 1-9 (2007) (Pubitemid 47625295)
55. D. P. McGovern, K. D. Taylor, C. Landers, C. Derkowski, D. Dutridge, M. Dubinsky, A. Ippoliti, E. Vasiliauskas, L. Mei, E. Mengesha, L. King, S. Pressman, S. R. Targan and J. I. Rotter: MAGI2 genetic variation and inflammatory bowel disease. Inflamm Bowel Dis, 15(1), 75-83 (2009)
56. K. Schneider, C. A. Benedict and C. F. Ware: A TRAFfic cop for host defense. Nat Immunol, 7(1), 15-6 (2006) (Pubitemid 41823863)
57. M. Saruta, S. R. Targan, L. Mei, A. F. Ippoliti, K. D. Taylor and J. I. Rotter: High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females. Inflamm Bowel Dis, 15(3), 321-7 (2009)
58. E. Latz, A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks, C. F. Knetter, E. Lien, N. J. Nilsen, T. Espevik and D. T. Golenbock: TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol, 5(2), 190-8 (2004) (Pubitemid 38208361)
59. M. Sioud: Induction of inflammatory cytokines and interferon responses by double-stranded and singlestranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol, 348(5), 1079-90 (2005) (Pubitemid 40602367)
60. T. K. Ghosh, D. J. Mickelson, J. Fink, J. C. Solberg, J. R. Inglefield, D. Hook, S. K. Gupta, S. Gibson and S. S. Alkan: Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. Cell Immunol, 243(1), 48-57 (2006)
61. G. Peng, Z. Guo, Y. Kiniwa, K. S. Voo, W. Peng, T. Fu, D. Y. Wang, Y. Li, H. Y. Wang and R. F. Wang: Tolllike receptor 8-mediated reversal of CD4+ regulatory T cell function. Science, 309(5739), 1380-4 (2005)
62. M. Sasai, M. M. Linehan and A. Iwasaki: Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science, 329(5998), 1530-4 (2010)
63. H. P. Torok, J. Glas, L. Tonenchi, G. Bruennler, M. Folwaczny and C. Folwaczny: Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology, 127(1), 365-6 (2004) (Pubitemid 38962306)
64. H. P. Torok, J. Glas, I. Endres, L. Tonenchi, M. Y. Teshome, M. Wetzke, W. Klein, P. Lohse, T. Ochsenkuhn, M. Folwaczny, B. Goke, C. Folwaczny, B. Muller-Myhsok and S. Brand: Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Am J Gastroenterol, 104(7), 1723-33 (2009)
65. W. Strober, P. J. Murray, A. Kitani and T. Watanabe: Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol, 6(1), 9-20 (2006) (Pubitemid 43279749)
66. N. Inohara, Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, S. J. Foster, A. P. Moran, J. L. Fernandez-Luna and G. Nunez: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem, 278(8), 5509-12 (2003) (Pubitemid 36800790)
67. T. Watanabe, A. Kitani, P. J. Murray and W. Strober: NOD2 is a negative regulator of Toll-like receptor 2- mediated T helper type 1 responses. Nat Immunol, 5(8), 800-8 (2004) (Pubitemid 39172973)
68. T. Watanabe, N. Asano, P. J. Murray, K. Ozato, P. Tailor, I. J. Fuss, A. Kitani and W. Strober: Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest, 118(2), 545-59 (2008) (Pubitemid 351206545)
69. T. Hisamatsu, M. Suzuki, H. C. Reinecker, W. J. Nadeau, B. A. McCormick and D. K. Podolsky: CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology, 124(4), 993-1000 (2003) (Pubitemid 36389802)
70. J. Wehkamp, J. Harder, M. Weichenthal, M. Schwab, E. Schaffeler, M. Schlee, K. R. Herrlinger, A. Stallmach, F. Noack, P. Fritz, J. M. Schroder, C. L. Bevins, K. Fellermann and E. F. Stange: NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut, 53(11), 1658-64 (2004) (Pubitemid 39434112)
71. L. A. Simms, J. D. Doecke, M. D. Walsh, N. Huang, E. V. Fowler and G. L. Radford-Smith: Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut, 57(7), 903-10 (2008) (Pubitemid 351919524)
72. T. S. Stappenbeck: The role of autophagy in Paneth cell differentiation and secretion. Mucosal Immunol, 3(1), 8-10 (2010)
73. M. J. Koslowski, I. Kubler, M. Chamaillard, E. Schaeffeler, W. Reinisch, G. Wang, J. Beisner, A. Teml, L. Peyrin-Biroulet, S. Winter, K. R. Herrlinger, P. Rutgeerts, S. Vermeire, R. Cooney, K. Fellermann, D. Jewell, C. L. Bevins, M. Schwab, E. F. Stange and J. Wehkamp: Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One, 4(2), e4496 (2009)
74. J. Wehkamp, G. Wang, I. Kubler, S. Nuding, A. Gregorieff, A. Schnabel, R. J. Kays, K. Fellermann, O. Burk, M. Schwab, H. Clevers, C. L. Bevins and E. F. Stange: The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol, 179(5), 3109-18 (2007)
75. H. W. Virgin and B. Levine: Autophagy genes in immunity. Nat Immunol, 10(5), 461-70 (2009)
76. N. Mizushima, Y. Ohsumi and T. Yoshimori: Autophagosome formation in mammalian cells. Cell Struct Funct, 27(6), 421-9 (2002) (Pubitemid 36267711)
77. S. B. Singh, W. Ornatowski, I. Vergne, J. Naylor, M. Delgado, E. Roberts, M. Ponpuak, S. Master, M. Pilli, E. White, M. Komatsu and V. Deretic: Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nat Cell Biol, 12(12), 1154-65 (2010)
78. S. B. Singh, A. S. Davis, G. A. Taylor and V. Deretic: Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science, 313(5792), 1438-41 (2006) (Pubitemid 44360272)
79. Y. O. Zhao, S. Konen-Waisman, G. A. Taylor, S. Martens and J. C. Howard: Localisation and mislocalisation of the interferon-inducible immunity-related GTPase, Irgm1 (LRG-47) in mouse cells. PLoS One, 5(1), e8648 (2010)
80. S. A. McCarroll, A. Huett, P. Kuballa, S. D. Chilewski, A. Landry, P. Goyette, M. C. Zody, J. L. Hall, S. R. Brant, J. H. Cho, R. H. Duerr, M. S. Silverberg, K. D. Taylor, J. D. Rioux, D. Altshuler, M. J. Daly and R. J. Xavier: Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet (2008)
81. T. Saitoh, N. Fujita, M. H. Jang, S. Uematsu, B. G. Yang, T. Satoh, H. Omori, T. Noda, N. Yamamoto, M. Komatsu, K. Tanaka, T. Kawai, T. Tsujimura, O. Takeuchi, T. Yoshimori and S. Akira: Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature, 456(7219), 264-8 (2008)
82. K. Cadwell, J. Y. Liu, S. L. Brown, H. Miyoshi, J. Loh, J. K. Lennerz, C. Kishi, W. Kc, J. A. Carrero, S. Hunt, C. D. Stone, E. M. Brunt, R. J. Xavier, B. P. Sleckman, E. Li, N. Mizushima, T. S. Stappenbeck and H. W. t. Virgin: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature, 456(7219), 259-63 (2008)
83. D. Q. Shih, S. R. Targan and D. McGovern: Recent advances in IBD pathogenesis: genetics and immunobiology. Curr Gastroenterol Rep, 10(6), 568-75 (2008)
84. F. Meylan, Y. J. Song, I. Fuss, S. Villarreal, E. Kahle, I. J. Malm, K. Acharya, H. L. Ramos, L. Lo, M. M. Mentink-Kane, T. A. Wynn, T. S. Migone, W. Strober and R. M. Siegel: The TNF-family cytokine TL1A drives IL-13- dependent small intestinal inflammation. Mucosal Immunol (2010)
85. V. Y. Taraban, T. J. Slebioda, J. E. Willoughby, S. L. Buchan, S. James, B. Sheth, N. R. Smyth, G. J. Thomas, E. C. Wang and A. Al-Shamkhani: Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol (2010)
86. D. Q. Shih, R. Barrett, X. Zhang, N. Yeager, K. H., P. Phaosawasdi, Y. Song, B. Ko, M. H. Wong, K. S. Michelsen, G. Martins, C. Pothoulakis and S. R. Targan: Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS One, 6(1), e16090 (2010)
87. W. S. Mow, E. A. Vasiliauskas, Y. C. Lin, P. R. Fleshner, K. A. Papadakis, K. D. Taylor, C. J. Landers, M. T. Abreu-Martin, J. I. Rotter, H. Yang and S. R. Targan: Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology, 126(2), 414-24 (2004) (Pubitemid 38182298)
88. I. D. Arnott, C. J. Landers, E. J. Nimmo, H. E. Drummond, B. K. Smith, S. R. Targan and J. Satsangi: Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol, 99(12), 2376-84 (2004) (Pubitemid 40039369)
89. K. S. Michelsen, L. S. Thomas, K. D. Taylor, Q. T. Yu, L. Mei, C. J. Landers, C. Derkowski, D. P. McGovern, J. I. Rotter and S. R. Targan: IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS One, 4(3), e4719 (2009)
90. R. M. Locksley, N. Killeen and M. J. Lenardo: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 104(4), 487-501 (2001) (Pubitemid 32201945)
91. G. W. Jones, J. S. Stumhofer, T. Foster, J. P. Twohig, P. Hertzog, N. Topley, A. S. Williams, C. A. Hunter, B. J. Jenkins, E. C. Wang and S. A. Jones: Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J (2010)
92. G. Bamias, C. Martin, 3rd, M. Marini, S. Hoang, M. Mishina, W. G. Ross, M. A. Sachedina, C. M. Friel, J. Mize, S. J. Bickston, T. T. Pizarro, P. Wei and F. Cominelli: Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol, 171(9), 4868-74 (2003) (Pubitemid 37310609)
93. J. L. Prehn, L. S. Thomas, C. J. Landers, Q. T. Yu, K. S. Michelsen and S. R. Targan: The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J Immunol, 178(7), 4033-8 (2007)
94. G. Bamias, M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro and F. Cominelli: Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc Natl Acad Sci U S A, 103(22), 8441-6 (2006)
95. J. L. Prehn, S. Mehdizadeh, C. J. Landers, X. Luo, S. C. Cha, P. Wei and S. R. Targan: Potential role for TL1A, the new TNF-family member and potent costimulator of IFNgamma, in mucosal inflammation. Clin Immunol, 112(1), 66-77 (2004) (Pubitemid 38781059)
96. K. A. Papadakis, C. Landers, J. Prehn, E. A. Kouroumalis, S. T. Moreno, J. C. Gutierrez-Ramos, M. R. Hodge and S. R. Targan: CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell
97. K. A. Papadakis, D. Zhu, J. L. Prehn, C. Landers, A. Avanesyan, G. Lafkas and S. R. Targan: Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFNgamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J Immunol, 174(8), 4985-90 (2005)
98. E. J. Kunkel, J. J. Campbell, G. Haraldsen, J. Pan, J. Boisvert, A. I. Roberts, E. C. Ebert, M. A. Vierra, S. B. Goodman, M. C. Genovese, A. J. Wardlaw, H. B. Greenberg, C. M. Parker, E. C. Butcher, D. P. Andrew and W. W. Agace: Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med, 192(5), 761-8 (2000)
99. K. A. Papadakis, J. Prehn, V. Nelson, L. Cheng, S. W. Binder, P. D. Ponath, D. P. Andrew and S. R. Targan: The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol, 165(9), 5069-76 (2000)
100. K. A. Papadakis, J. Prehn, S. T. Moreno, L. Cheng, E. A. Kouroumalis, R. Deem, T. Breaverman, P. D. Ponath, D. P. Andrew, P. H. Green, M. R. Hodge, S. W. Binder and S. R. Targan: CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology, 121(2), 246-54 (2001) (Pubitemid 32729371)
101. D. Q. Shih, L. Y. Kwan, V. Chavez, O. Cohavy, R. Gonsky, E. Y. Chang, C. Chang, C. O. Elson and S. R. Targan: Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur J Immunol, 39(11), 3239-50 (2009)
102. F. Meylan, T. S. Davidson, E. Kahle, M. Kinder, K. Acharya, D. Jankovic, V. Bundoc, M. Hodges, E. M. Shevach, A. Keane-Myers, E. C. Wang and R. M. Siegel: The TNFfamily receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity, 29(1), 79-89 (2008)
103. N. Kamada, T. Hisamatsu, H. Honda, T. Kobayashi, H. Chinen, T. Takayama, M. T. Kitazume, S. Okamoto, K. Koganei, A. Sugita, T. Kanai and T. Hibi: TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm Bowel Dis, 16(4), 568-75 (2010)
104. K. Endo, Y. Kinouchi, Y. Kakuta, N. Ueki, S. Takahashi and T. Shimosegawa: Involvement of NF-kappa B pathway in TL1A gene expression induced by lipopolysaccharide. Cytokine (2009)
105. E. Biener-Ramanujan, R. Gonsky, B. Ko and S. R. Targan: Functional signaling of membrane-bound TL1A induces IFN-gamma expression. FEBS Lett, 584(11), 2376-80 (2010)
106. H. Takedatsu, K. S. Michelsen, B. Wei, C. J. Landers, L. S. Thomas, D. Dhall, J. Braun and S. R. Targan: TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology, 135(2), 552-67 (2008)
107. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley and B. Stockinger: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells. Immunity, 24(2), 179-89 (2006) (Pubitemid 43214587)
108. E. Bettelli, T. Korn, M. Oukka and V. K. Kuchroo: Induction and effector functions of T(H)17 cells. Nature, 453(7198), 1051-7 (2008)
109. P. R. Mangan, L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb and C. T. Weaver: Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 441(7090), 231-4 (2006)
110. T. H. Schreiber, D. Wolf, M. S. Tsai, J. Chirinos, V. V. Deyev, L. Gonzalez, T. R. Malek, R. B. Levy and E. R. Podack: Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J Clin Invest, 120(10), 3629-40 (2010)
111. A. Sakuraba, T. Sato, N. Kamada, M. Kitazume, A. Sugita and T. Hibi: Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology, 137(5), 1736-45 (2009)
112. A. M. Jetten: Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr Drug Targets Inflamm Allergy, 3(4), 395-412 (2004) (Pubitemid 39534775)
113. C. L. Langrish, Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein and D. J. Cua: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med, 201(2), 233-40 (2005) (Pubitemid 40189432)
114. L. Zhou, Ivanov, II, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard and D. R. Littman: IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol, 8(9), 967-74 (2007) (Pubitemid 47300011)
115. C. Dong and R. I. Nurieva: Regulation of immune and autoimmune responses by ICOS. J Autoimmun, 21(3), 255-60 (2003) (Pubitemid 37410113)
116. C. Dong: TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol, 8(5), 337-48 (2008) (Pubitemid 351595217)
117. C. A. Hunter: New IL-12-family members: IL-23 and IL- 27, cytokines with divergent functions. Nat Rev Immunol, 5(7), 521-31 (2005) (Pubitemid 40961330)
118. N. Kamada, T. Hisamatsu, S. Okamoto, H. Chinen, T. Kobayashi, T. Sato, A. Sakuraba, M. T. Kitazume, A. Sugita, K. Koganei, K. S. Akagawa and T. Hibi: Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest, 118(6), 2269-80 (2008) (Pubitemid 351872344)
119. M. C. Kullberg, D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy and A. Sher: IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med, 203(11), 2485-94 (2006) (Pubitemid 44664618)
120. D. Yen, J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, B. McKenzie, M. A. Kleinschek, A. Owyang, J. Mattson, W. Blumenschein, E. Murphy, M. Sathe, D. J. Cua, R. A. Kastelein and D. Rennick: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL- 17 and IL-6. J Clin Invest, 116(5), 1310-6 (2006)
121. S. Hue, P. Ahern, S. Buonocore, M. C. Kullberg, D. J. Cua, B. S. McKenzie, F. Powrie and K. J. Maloy: Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med, 203(11), 2473-83 (2006) (Pubitemid 44664617)
122. S. Buonocore, P. P. Ahern, H. H. Uhlig, Ivanov, II, D. R. Littman, K. J. Maloy and F. Powrie: Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature, 464(7293), 1371-5 (2010)
123. P. J. Mannon, I. J. Fuss, L. Mayer, C. O. Elson, W. J. Sandborn, D. Present, B. Dolin, N. Goodman, C. Groden, R. L. Hornung, M. Quezado, Z. Yang, M. F. Neurath, J. Salfeld, G. M. Veldman, U. Schwertschlag and W. Strober: Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med, 351(20), 2069-79 (2004) (Pubitemid 39482500)
124. W. J. Sandborn, B. G. Feagan, R. N. Fedorak, E. Scherl, M. R. Fleisher, S. Katz, J. Johanns, M. Blank and P. Rutgeerts: A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology, 135(4), 1130-41 (2008)
125. K. A. Papp, R. G. Langley, M. Lebwohl, G. G. Krueger, P. Szapary, N. Yeilding, C. Guzzo, M. C. Hsu, Y. Wang, S. Li, L. T. Dooley and K. Reich: Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebocontrolled trial (PHOENIX 2). Lancet, 371(9625), 1675-84 (2008) (Pubitemid 351671884)
126. C. L. Leonardi, A. B. Kimball, K. A. Papp, N. Yeilding, C. Guzzo, Y. Wang, S. Li, L. T. Dooley and K. B. Gordon: Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet, 371(9625), 1665-74 (2008) (Pubitemid 351671883)
127. Z. Yao, W. C. Fanslow, M. F. Seldin, A. M. Rousseau, S. L. Painter, M. R. Comeau, J. I. Cohen and M. K. Spriggs: Herpesvirus Saimiri encodes a new cytokine, IL- 17, which binds to a novel cytokine receptor. Immunity, 3(6), 811-21 (1995) (Pubitemid 26091152)
128. T. Shalom-Barak, J. Quach and M. Lotz: Interleukin- 17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem, 273(42), 27467-73 (1998)
129. J. K. Kolls and A. Linden: Interleukin-17 family members and inflammation. Immunity, 21(4), 467-76 (2004) (Pubitemid 39370503)
130. T. A. Moseley, D. R. Haudenschild, L. Rose and A. H. Reddi: Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev, 14(2), 155-74 (2003) (Pubitemid 36389528)
131. S. Fujino, A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba and Y. Fujiyama: Increased expression of interleukin 17 in inflammatory bowel disease. Gut, 52(1), 65-70 (2003) (Pubitemid 36020767)
132. H. Park, Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian and C. Dong: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol, 6(11), 1133-41 (2005) (Pubitemid 41541791)
133. K. A. Bush, K. M. Farmer, J. S. Walker and B. W. Kirkham: Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum, 46(3), 802-5 (2002) (Pubitemid 34214263)
134. Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo and Y. Iwakura: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol, 177(1), 566-73 (2006) (Pubitemid 43939170)
135. Z. Zhang, M. Zheng, J. Bindas, P. Schwarzenberger and J. K. Kolls: Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis, 12(5), 382-8 (2006)
136. M. Sarra, F. Pallone, T. T. Macdonald and G. Monteleone: IL-23/IL-17 axis in IBD. Inflamm Bowel Dis, 16(10), 1808-13 (2010)
137. W. O'Connor, Jr., M. Kamanaka, C. J. Booth, T. Town, S. Nakae, Y. Iwakura, J. K. Kolls and R. A. Flavell: A protective function for interleukin 17A in T cellmediated intestinal inflammation. Nat Immunol, 10(6), 603-9 (2009)
138. C. L. Langrish, B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein and D. J. Cua: IL-12 and IL- 23: master regulators of innate and adaptive immunity. Immunol Rev, 202, 96-105 (2004) (Pubitemid 39576907)
139. A. C. Mullen, F. A. High, A. S. Hutchins, H. W. Lee, A. V. Villarino, D. M. Livingston, A. L. Kung, N. Cereb, T. P. Yao, S. Y. Yang and S. L. Reiner: Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science, 292(5523), 1907-10 (2001) (Pubitemid 32538365)
140. W. E. Thierfelder, J. M. van Deursen, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. Vignali, P. C. Doherty, G. C. Grosveld and J. N. Ihle: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature, 382(6587), 171-4 (1996) (Pubitemid 26242884)
141. Y. Yang, J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke and A. E. Lovett-Racke: T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J Exp Med, 206(7), 1549-64 (2009)
142. D. Luger, P. B. Silver, J. Tang, D. Cua, Z. Chen, Y. Iwakura, E. P. Bowman, N. M. Sgambellone, C. C. Chan and R. R. Caspi: Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med, 205(4), 799-810 (2008) (Pubitemid 351549879)
143. F. Powrie, M. W. Leach, S. Mauze, S. Menon, L. B. Caddle and R. L. Coffman: Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity, 1(7), 553-62 (1994)
144. G. Monteleone, L. Biancone, R. Marasco, G. Morrone, O. Marasco, F. Luzza and F. Pallone: Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology, 112(4), 1169-78 (1997) (Pubitemid 27157528)
145. W. Hans, J. Scholmerich, V. Gross and W. Falk: Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur Cytokine Netw, 11(1), 67-74 (2000) (Pubitemid 30145404)
146. M. F. Neurath, I. Fuss, B. L. Kelsall, E. Stuber and W. Strober: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med, 182(5), 1281-90 (1995)
147. C. E. Hornquist, X. Lu, P. M. Rogers-Fani, U. Rudolph, S. Shappell, L. Birnbaumer and G. R. Harriman: G(alpha)i2- deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J Immunol, 158(3), 1068-77 (1997) (Pubitemid 127469926)
148. P. Revy, M. Sospedra, B. Barbour and A. Trautmann: Functional antigen-independent synapses formed between T cells and dendritic cells. Nat Immunol, 2(10), 925-31 (2001) (Pubitemid 32976164)
149. F. Benvenuti, C. Lagaudriere-Gesbert, I. Grandjean, C. Jancic, C. Hivroz, A. Trautmann, O. Lantz and S. Amigorena: Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. J Immunol, 172(1), 292-301 (2004) (Pubitemid 38020483)
150. M. Tourret, S. Guegan, K. Chemin, S. Dogniaux, F. Miro, A. Bohineust and C. Hivroz: T cell polarity at the immunological synapse is required for CD154-dependent IL- 12 secretion by dendritic cells. J Immunol, 185(11), 6809-18 (2010)
151. A. Kupfer, T. R. Mosmann and H. Kupfer: Polarized expression of cytokines in cell conjugates of helper T cells and splenic B cells. Proc Natl Acad Sci U S A, 88(3), 775-9 (1991) (Pubitemid 21916106)
152. M. Faroudi, C. Utzny, M. Salio, V. Cerundolo, M. Guiraud, S. Muller and S. Valitutti: Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold. Proc Natl Acad Sci U S A, 100(24), 14145-50 (2003) (Pubitemid 37499205)
153. S. R. Bennett, F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller and W. R. Heath: Help for cytotoxic-Tcell responses is mediated by CD40 signalling. Nature, 393(6684), 478-80 (1998)
154. S. P. Schoenberger, R. E. Toes, E. I. van der Voort, R. Offringa and C. J. Melief: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature, 393(6684), 480-3 (1998)
155. J. P. Ridge, F. Di Rosa and P. Matzinger: A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature, 393(6684), 474-8 (1998)
156. M. H. Lexberg, A. Taubner, I. Albrecht, I. Lepenies, A. Richter, T. Kamradt, A. Radbruch and H. D. Chang: IFN-gamma and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol, 40(11), 3017-27 (2010)
157. L. Gorelik, S. Constant and R. A. Flavell: Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med, 195(11), 1499-505 (2002) (Pubitemid 34602827)
158. L. E. Harrington, R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy and C. T. Weaver: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol, 6(11), 1123-32 (2005) (Pubitemid 41541790)
159. M. Saruta, K. S. Michelsen, L. S. Thomas, Q. T. Yu, C. J. Landers and S. R. Targan: TLR8-mediated activation of human monocytes inhibits TL1A expression. Eur J Immunol, 39(8), 2195-202 (2009)
160. L. H. Travassos, L. A. Carneiro, M. Ramjeet, S. Hussey, Y. G. Kim, J. G. Magalhaes, L. Yuan, F. Soares, E. Chea, L. Le Bourhis, I. G. Boneca, A. Allaoui, N. L. Jones, G. Nunez, S. E. Girardin and D. J. Philpott: Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol, 11(1), 55-62 (2010)
161. C. R. Homer, A. L. Richmond, N. A. Rebert, J. P. Achkar and C. McDonald: ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology, 139(5), 1630-41, 1641 e1-2 (2010)
162. R. M. Cooney, J. S. Baker, A. Simmons and D. P. Jewell: NOD2 activation by muramyl dipeptide induces autophagy in dendritic cells in an ATG16L1 dependent pathway. Gastroenterology, 134(4, Suppl. 1), A514 (2008)
163. K. Cadwell, K. K. Patel, N. S. Maloney, T. C. Liu, A. C. Ng, C. E. Storer, R. D. Head, R. Xavier, T. S. Stappenbeck and H. W. Virgin: Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell, 141(7), 1135-45 (2010)
164. K. Cadwell, K. K. Patel, N. S. Maloney, T. C. Liu, A. C. Ng, C. E. Storer, R. D. Head, R. Xavier, T. S. Stappenbeck and H. W. Virgin: Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell, 141(7), 1135-45 (2010)